Pablo de Renteria

Stock Analyst at Kepler Capital

(0.35)
# 4,224
Out of 4,501 analysts
355
Total ratings
41%
Success rate
-4.2%
Average return

Stocks Rated by Pablo de Renteria

bioMérieux S.A.
Jun 25, 2026
Maintained: Buy
Price Target: €85.00
Current: $71.65
Upside: +18.63%
DiaSorin S.p.A.
Jun 25, 2026
Maintained: Buy
Price Target: €76.00
Current: $69.54
Upside: +9.29%
Lonza Group AG
May 8, 2026
Maintained: Buy
Price Target: CHF 670.00
Current: $582.60
Upside: +15.00%
Indra Sistemas, S.A.
May 6, 2026
Maintained: Buy
Price Target: €76.00
Current: $49.60
Upside: +53.23%
Laboratorios Farmaceuticos Rovi, S.A.
May 6, 2026
Maintained: Buy
Price Target: €90.00€83.00
Current: $56.15
Upside: +47.82%
Viscofan, S.A.
Apr 24, 2026
Maintained: Buy
Price Target: €74.00
Current: $57.00
Upside: +29.82%
Siegfried Holding AG
Apr 24, 2026
Maintained: Hold
Price Target: CHF 85.00
Current: $72.45
Upside: +17.32%
Ebro Foods, S.A.
Feb 24, 2026
Maintained: Hold
Price Target: €18.10
Current: $18.16
Upside: -0.33%
Almirall, S.A.
Feb 23, 2026
Maintained: Buy
Price Target: €13.30€14.20
Current: $11.48
Upside: +23.69%
Fluidra, S.A.
Jul 31, 2025
Maintained: Sell
Price Target: €19.20
Current: $18.95
Upside: +1.32%
Maintained: Hold
Price Target: €4.30
Current: $3.29
Upside: +30.54%
Maintained: Buy
Price Target: €4.20
Current: $2.42
Upside: +73.84%
Maintained: Buy
Price Target: €5.00
Current: $2.50
Upside: n/a
Maintained: Buy
Price Target: $19
Current: $7.29
Upside: n/a
Initiated Coverage: Buy
Price Target: €17.50
Current: $8.99
Upside: n/a
Maintained: Buy
Price Target: 9,500p
Current: $13,354.00
Upside: n/a
Maintained: Buy
Price Target: €99.00€105.00
Current: $76.48
Upside: n/a
Maintained: Buy
Price Target: €5.00€10.70
Current: $2.65
Upside: n/a
Downgraded: Hold
Price Target: €28.70€32.00
Current: $55.40
Upside: n/a
Maintained: Buy
Price Target: €2.35
Current: $0.637
Upside: n/a
Maintained: Hold
Price Target: €120.00
Current: $76.50
Upside: n/a